BAOZUN-W (09991.HK): Authorizes Management to Launch New US$10mn Share Buyback Program
NewTimeSpace News: On 24 September 2026, Baozun Inc. (the "Company") announced that it filed a Form 6-K with the United States Securities and Exchange Commission on 24 September 2026 in respect of a press release regarding the authorization of the Company's management to establish and implement a new US$10 million share repurchase program; this announcement constitutes an overseas regulatory announcement and an inside information announcement.
The announcement disclosed that the Company's repurchases of shares in the market will be subject to market conditions and will be made at the full discretion of the board of directors and/or its authorized persons; the Company gives no assurance as to the timing, quantity or price of any share repurchases, or whether it will carry out any repurchase at all.
The Company stated that it operates under a weighted voting rights structure whereby each Class A ordinary share carries one vote and each Class B ordinary share carries ten votes; its American depositary shares (each representing three Class A ordinary shares) are listed on the Nasdaq Global Select Market under the ticker BZUN. The full text of the Form 6-K is available on the SEC's website (www.sec.gov) and the Company's website (www.baozun.com); shareholders and potential investors are advised to exercise caution when dealing in the Company's securities.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HARBIN ELECTRIC (01133.HK): Buys 100% of Ocean Smart Equipment from Parent for RMB 14.86mn; Connected Transaction
- UNITED LAB (03933.HK): NMPA Accepts Filing for IDegLira; First Chinese Biosimilar Applicant
- HANSOH PHARMA (03692.HK): NMPA Accepts NDA for HS-20093, Its B7-H3-Targeting ADC, in Osteosarcoma
- WENYE GROUP (01802.HK): Jiang Jun Appointed Chairman as Kong Guojing Resigns; Shares Remain Suspended
- REDCO GROUP (01622.HK): Cayman and HK Scheme Meetings for Debt Restructuring Set for 16 October